TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic.

Authors:
Smith KL; Mead-Harvey C; Mazza GL; Shinn EH; Frank ES and 9 more

Journal:
Cancer Med

Publication Year: 2024

DOI:
10.1002/cam4.7090

PMCID:
PMC10926883

PMID:
38466037

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Cancer Med

Detailed journal information not available.

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

4/6

66.7% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Evidence found in paper:

"data s1."

Code Sharing

COI Disclosure

Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT Dr. Smith receiving research grants to institution from Pfizer, spouse has stock in Abbvie and Abbott Labs, and is currently employed at AstraZeneca. Dr. Melisko receives research funding from OBI Pharma, Daehwa, and Novartis. Dr. Rocque received research funding from Genentech, Pfizer, and Carevive and consulting fees for Genentech and Pfizer."

Funding Disclosure

Evidence found in paper:

"FUNDING INFORMATION This work was conducted by the Translational Breast Cancer Research Consortium and supported by the Metastatic Breast Cancer Network."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025